The First Affiliated Hospital Of University Of Science And Technology Of China
Clinical trials sponsored by The First Affiliated Hospital Of University Of Science And Technology Of China, explained in plain language.
-
New combo therapy aims to boost stroke recovery
Disease control Not yet recruitingThis study tests whether adding baricitinib to standard clot removal helps people recover better after a severe stroke. About 750 adults with a large-vessel stroke will receive baricitinib or a placebo right after treatment. The main goal is to see if the drug reduces disability …
Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated May 17, 2026 11:35 UTC
-
Could a simple shot replace surgery for some strokes?
Disease control Not yet recruitingThis study tests whether the drug tenecteplase can help people who have had a major stroke but cannot get surgery to remove the clot. About 794 adults will receive either the drug or standard care within 4.5 to 24 hours of their first symptoms. The main goal is to see if more peo…
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy aims to wipe out high-risk rectal cancer before surgery
Disease control Not yet recruitingThis study tests whether combining chemotherapy, radiation, and an immunotherapy drug can completely eliminate tumors in people with locally advanced rectal cancer that has a high chance of coming back. About 30 participants will receive this treatment before any surgery. The mai…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated May 13, 2026 15:59 UTC